DelveInsight’s “Non-radiographic Axial Spondyloarthritis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Non-radiog… Read More
Arthritis is a term used to describe a group of diseases that primarily affect the joints in the body. It refers to inflammation and swelling of one or more joints, leading to pain… Read More
DelveInsight Business Research LLP
DelveInsight’s “Inflammatory bowel disease Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth unde… Read More
Ulcerative Colitis Market
DelveInsight’s Ulcerative Colitis Market report offers a detailed comprehension of the Ulcerative Colitis market size by treatment, epidemiology, an… Read More
In 2001, the FDA approved Imatinib, the first drug to be developed by targeting a specific protein kinase and the first molecularly targeted drug to fight cancer. It was considered a milesto… Read More
After the (small) market correction in February and the stocks with bullish growth last year cooling down it might be time to look at other types of stocks. While I usually do not invest in… Read More
A company that’s 60 per cent owned by Schneider Electric is buying a company that’s 44.7 per cent owned by Softbank. That’s all we have to work with today. Perhaps we can t… Read More
Gilead’s stock is up as its drug remdesivir is the only
medicine approved for treatment of Covid-19, but it is also well-positioned to
benefit from a world of recurring pandemics… Read More
fernandozhiminaicela / Pixabay
The News:
Since its birthday back in 1776, America has seen itself as the land of the new–and Europe as a landmass caught in the past. Nowhere is that tr… Read More
Galapagos NV (GLPG NA) seems to have got some investor attention after the successful results of Celgene Corp (CELG US) anti-inflammatory product candidate for the treatment of Cro… Read More